Who Paid My Doc
Risa Kagan
Obstetrics & Gynecology Berkeley, CA Medical Doctor
NPI 1336255660 CMS profile 14952
2500 Milvia St, Berkeley, CA 94704
General payments
$496,517
Research payments
$6,691
Ownership & investment interest
$0
Research they led as principal investigator
$10,274
Through program year 2025, Risa Kagan of Berkeley, CA is reported in the CMS Open Payments database as having received $496,517 across 457 general payments and $6,691 in research payments paid to them. Separately, studies naming them as principal investigator received $10,274 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $116,604 | 100 | |
| 2024 | General | $99,668 | 78 | |
| 2023 | General | $105,804 | 87 | |
| 2023 | Research | $3,163 | 5 | |
| 2022 | General | $44,980 | 21 | |
| 2021 | General | $2,570 | 5 | |
| 2021 | Research | $189 | 1 | |
| 2020 | General | $29,260 | 19 | |
| 2020 | Research | $3,340 | 1 | |
| 2019 | General | $97,630 | 147 |
Beside peers
- Risa Kagan
- Obstetrics & Gynecology median
- Middle half of Obstetrics & Gynecology
- National median
In program year 2025, general payments to Risa Kagan were reported at $116,604. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.
Show as a table
| Year | Risa Kagan | Obstetrics & Gynecology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $97,630 | $172 | $62–$391 | $163 |
| 2020 | $29,260 | $94 | $36–$222 | $114 |
| 2021 | $2,570 | $136 | $42–$369 | $132 |
| 2022 | $44,980 | $160 | $50–$433 | $149 |
| 2023 | $105,804 | $169 | $56–$423 | $160 |
| 2024 | $99,668 | $152 | $50–$371 | $164 |
| 2025 | $116,604 | $158 | $51–$401 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
464 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Obstetrics & Gynecology in California
Steve Yu
Obstetrics & Gynecology · Northridge, CA
Samir Hage
Obstetrics & Gynecology · Redlands, CA
Malcolm Munro
Obstetrics & Gynecology · Los Angeles, CA
Michael Krychman
Obstetrics & Gynecology · Costa Mesa, CA
Anita Nelson
Obstetrics & Gynecology · Torrance, CA
Jan Segnitz
Obstetrics & Gynecology · San Jose, CA
Related records
Obstetrics & Gynecology in California
Practitioners in the same specialty and state, ranked by reported value.
All Obstetrics & Gynecology
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.